Han Biomedical (ROCO:6999) OCF Margin %: 13.63% (As of Dec. 2025) — 49% Below Median


ROCO:6999 Han Biomedical Inc ROCO:6999
25 GF Score
Price NT$30.00
! 1 Warning Sign
View Full Analysis

What is Han Biomedical OCF Margin %?

Han Biomedical ROCO:6999 +0.17% 25 OCF Margin % is 13.63% as of Dec. 2025, which is 49% below its 10-year median of 26.82. GuruFocus rates ROCO:6999 with a GF Score™ of 25/100. The stock has 1 warning sign investors should review. Among 949 Biotechnology companies, Han Biomedical ranks better than 84.19% on this metric.

OCF Margin % is calculated as Cash Flow from Operations divided by its Revenue. Han Biomedical's Cash Flow from Operations for the six months ended in Dec. 2025 was NT$8.9 Mil. Han Biomedical's Revenue for the six months ended in Dec. 2025 was NT$65.4 Mil. Therefore, Han Biomedical's OCF Margin % for the quarter that ended in Dec. 2025 was 13.63%.

As of today, Han Biomedical's current OCF Yield % is 4.02%.

The historical rank and industry rank for Han Biomedical's OCF Margin % or its related term are showing as below:

ROCO:6999' s OCF Margin % Range Over the Past 10 Years
Min: 20.99   Med: 26.82   Max: 42.75
Current: 20.99

During the past 5 years, the highest OCF Margin % of Han Biomedical was 42.75%. The lowest was 20.99%. And the median was 26.82%.

ROCO:6999's OCF Margin % is ranked better than
84.19% of 949 companies
in the Biotechnology industry
Industry Median: -64.23 vs ROCO:6999: 20.99

Han Biomedical OCF Margin % Related Terms

Han Biomedical OCF Margin % Historical Data

* Premium members only.

The historical data trend for Han Biomedical's OCF Margin % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Han Biomedical OCF Margin % Chart

Han Biomedical Annual Data
Trend Dec21 Dec22 Dec23 Dec24 Dec25
OCF Margin %
42.75 24.86 31.90 26.82 20.99

Han Biomedical Semi-Annual Data
Dec21 Dec22 Jun23 Dec23 Jun24 Dec24 Jun25 Dec25
OCF Margin % Get a 7-Day Free Trial 14.56 26.60 27.00 28.91 13.63

ROCO:6999 vs VRTX, REGN, ALNY: OCF Margin % Comparison

For the Biotechnology subindustry, Han Biomedical's OCF Margin %, along with its competitors' market caps and OCF Margin % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Han Biomedical OCF Margin % vs Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Han Biomedical's OCF Margin % distribution charts can be found below:

* The bar in red indicates where Han Biomedical's OCF Margin % falls into.


ROCO:6999
25GF Score
Han Biomedical Inc ROCO:6999
OCF Margin % is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Han Biomedical OCF Margin % Calculation

OCF Margin % is the ratio of Cash Flow from Operations divided by net sales or Revenue, usually presented in percent.

Han Biomedical's OCF Margin for the fiscal year that ended in Dec. 2025 is calculated as

OCF Margin=Cash Flow from Operations (A: Dec. 2025 )/Revenue (A: Dec. 2025 )
=26.496/126.209
=20.99 %

Han Biomedical's OCF Margin for the quarter that ended in Dec. 2025 is calculated as

OCF Margin=Cash Flow from Operations (Q: Dec. 2025 )/Revenue (Q: Dec. 2025 )
=8.913/65.393
=13.63 %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about OCF Margin % →
What does a OCF Margin % of 13.63% mean?
Han Biomedical (ROCO:6999) has a OCF Margin % of 13.63% as of Dec. 2025. OCF Margin is the ratio of Cash Flow from Operations to Total Revenue. View historical data on Han Biomedical and its competitors. This is 49% below median its historical median of 26.82. Over the past decade, Han Biomedical's OCF Margin % has ranged from 20.99 to 42.75. According to the industry distribution chart, Han Biomedical ranks #150 out of 949 companies in the Biotechnology industry, placing it in the top 15.8%.
Is Han Biomedical's OCF Margin % too high?
Han Biomedical's current OCF Margin % of 13.63% is 49% below median its 10-year median of 26.82. Over the past 10 years, this metric has ranged from a low of 20.99 to a high of 42.75. Based on the distribution chart, Han Biomedical ranks #150 out of 949 companies in the Biotechnology industry, which is in the top quartile — a strong position relative to peers. Overall, Han Biomedical has a GF Score™ of 25/100, reflecting its overall financial health beyond just this single metric.
How does Han Biomedical's OCF Margin % compare to VRTX and REGN?
According to the Biotechnology industry distribution chart, Han Biomedical ranks #150 out of 949 companies for OCF Margin %. This places Han Biomedical in the top 16% of its industry — outperforming the majority of peers. Historically, Han Biomedical's own OCF Margin % has ranged from 20.99 to 42.75 over the past decade. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good OCF Margin % for a Biotechnology company?
A good OCF Margin % depends on the Biotechnology industry context. However, OCF Margin % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high OCF Margin % mean?
A high OCF Margin % can signal that a stock is expensive relative to its fundamentals. OCF Margin is the ratio of Cash Flow from Operations to Total Revenue. View historical data on Han Biomedical and its competitors. Han Biomedical's current OCF Margin % is 13.63%, which is 49% below median its own 10-year median of 26.82. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Han Biomedical stock overvalued right now?
Han Biomedical (ROCO:6999) has a current OCF Margin % of 13.63%. The current OCF Margin % is 13.63%, which is 49% below median its 10-year median of 26.82. Han Biomedical's overall GF Score™ is 25/100 with 1 warning sign to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is OCF Margin % calculated?
OCF Margin % is calculated from a company's financial statements. For Han Biomedical (ROCO:6999), the current OCF Margin % is 13.63% as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Han Biomedical Business Description

Address Xintai 5th Road, 15F-11, No.99, Sec.1, Xizhi District, New Taipei City, TWN
Han Biomedical Inc operates as a bio-material technology platform for the tissue repair market.
25GF Score

Get the complete analysis for ROCO:6999

OCF Margin % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

NT$30.00
Price